RS67133B1 - Liofilizovane kompozicije velike površine koje sadrže arsen za oralnu administraciju kod pacijenta - Google Patents
Liofilizovane kompozicije velike površine koje sadrže arsen za oralnu administraciju kod pacijentaInfo
- Publication number
- RS67133B1 RS67133B1 RS20250815A RSP20250815A RS67133B1 RS 67133 B1 RS67133 B1 RS 67133B1 RS 20250815 A RS20250815 A RS 20250815A RS P20250815 A RSP20250815 A RS P20250815A RS 67133 B1 RS67133 B1 RS 67133B1
- Authority
- RS
- Serbia
- Prior art keywords
- arsenic
- patients
- area
- oral administration
- high surface
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/36—Arsenic; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562110574P | 2015-02-01 | 2015-02-01 | |
| US201562142709P | 2015-04-03 | 2015-04-03 | |
| EP21192594.6A EP3981414B1 (en) | 2015-02-01 | 2016-02-01 | High surface-area lyophilized compositions comprising arsenic for oral administration in patients |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS67133B1 true RS67133B1 (sr) | 2025-09-30 |
Family
ID=56544541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20250815A RS67133B1 (sr) | 2015-02-01 | 2016-02-01 | Liofilizovane kompozicije velike površine koje sadrže arsen za oralnu administraciju kod pacijenta |
Country Status (20)
| Country | Link |
|---|---|
| US (6) | US10111836B2 (sr) |
| EP (3) | EP4599823A1 (sr) |
| JP (3) | JP6928768B2 (sr) |
| CN (2) | CN117899029A (sr) |
| AU (4) | AU2016211186A1 (sr) |
| CA (2) | CA2975406C (sr) |
| DK (1) | DK3981414T3 (sr) |
| ES (2) | ES2899226T3 (sr) |
| FI (1) | FI3981414T3 (sr) |
| HR (1) | HRP20251032T1 (sr) |
| HU (1) | HUE072537T2 (sr) |
| LT (1) | LT3981414T (sr) |
| MX (2) | MX390835B (sr) |
| PL (1) | PL3981414T3 (sr) |
| PT (1) | PT3981414T (sr) |
| RS (1) | RS67133B1 (sr) |
| SI (1) | SI3981414T1 (sr) |
| SM (1) | SMT202500321T1 (sr) |
| TW (3) | TW202337477A (sr) |
| WO (1) | WO2016123603A2 (sr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HRP20251032T1 (hr) | 2015-02-01 | 2025-10-24 | Quetzal Therapeutics, Llc | Liofilizirani pripravci s visokim površinskim područjem koji sadrže arsen za oralnu primjenu kod pacijenata |
| MX384297B (es) | 2016-12-01 | 2025-03-14 | Eupharma Pty Ltd | Composiciones de arsénico. |
| KR101844049B1 (ko) * | 2016-12-05 | 2018-03-30 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 간암 예방 또는 치료용 약학 조성물 |
| KR101844050B1 (ko) | 2016-12-09 | 2018-05-14 | 주식회사 케마스 | 육산화사비소의 결정다형을 포함하는 암 예방 또는 치료용 약학 조성물 |
| US20190374611A1 (en) * | 2017-01-18 | 2019-12-12 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment patients suffering from myeloproliferative disorders |
| US11583552B2 (en) * | 2021-02-17 | 2023-02-21 | Manoj Maniar | Pharmaceutical formulation of arsenic trioxide |
| JP7428842B1 (ja) | 2023-03-29 | 2024-02-06 | ａｒｔｉｅｎｃｅ株式会社 | 活性エネルギー線硬化型インキ、その製造方法、および印刷物 |
| WO2025172482A1 (en) * | 2024-02-14 | 2025-08-21 | Institut Gustave Roussy | Oral composition of arsenic trioxide for cancer treatment |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5773419A (en) | 1995-03-03 | 1998-06-30 | Falcon; Juan | Method of treating cancer with tannic acid |
| CN1044559C (zh) | 1995-08-23 | 1999-08-11 | 哈尔滨医科大学附属第一医院 | 抗白血病、肝癌、淋巴瘤注射液 |
| IL136051A0 (en) | 1997-11-10 | 2001-05-20 | Sloan Kettering Inst Cancer | Process for producing arsenic trioxide formulations and methods for treating cancer using arsenic trioxide or melarsoprol |
| US7276359B1 (en) * | 1998-03-13 | 2007-10-02 | Wyeth | Polynucleotide composition, method of preparation, and use thereof |
| CN1131922C (zh) | 1998-10-19 | 2003-12-24 | 张在喆 | 一种通过弹性键搭架与收拢的帐篷 |
| US7374779B2 (en) | 1999-02-26 | 2008-05-20 | Lipocine, Inc. | Pharmaceutical formulations and systems for improved absorption and multistage release of active agents |
| CN101385732A (zh) * | 2000-02-29 | 2009-03-18 | 布里斯托尔-迈尔斯斯奎布公司 | 低剂量艾替开韦制剂及其应用 |
| AUPR874601A0 (en) * | 2001-11-08 | 2001-11-29 | Unisearch Limited | Selective targeting of apoptotic cells |
| US7521071B2 (en) | 2002-10-09 | 2009-04-21 | Versitech Limited | Formulation of oral compositions comprising arsenic trioxide and methods of use thereof |
| US8906422B2 (en) | 2002-10-09 | 2014-12-09 | The University Of Hong Kong | Method for inhibiting cancer using arsenic trioxide |
| GB0315632D0 (en) * | 2003-07-04 | 2003-08-13 | West Pharm Serv Drug Res Ltd | Pharmaceutical formulations |
| CN1251688C (zh) | 2003-12-09 | 2006-04-19 | 重庆维特瑞医药开发有限公司 | 三氧化二砷冻干粉针及其生产方法 |
| JP4292985B2 (ja) | 2003-12-25 | 2009-07-08 | Ｊｓｒ株式会社 | 感放射線性組成物、マイクロレンズとその形成方法および液晶表示素子 |
| CN1698650A (zh) | 2004-05-21 | 2005-11-23 | 哈尔滨伊达药业有限公司 | 一种治疗原发性肝癌的亚砷酸注射液及其制备方法 |
| CN1326528C (zh) | 2004-07-13 | 2007-07-18 | 东南大学 | 砒霜磁性纳米明胶微球的制备工艺 |
| WO2007069272A2 (en) | 2005-10-21 | 2007-06-21 | Panacea Biotec Limited | Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| US20080089951A1 (en) * | 2006-10-11 | 2008-04-17 | The University Of Hong Kong | Method for Inhibiting Cancer Using Arsenic Trioxide |
| CN101322719B (zh) | 2007-06-15 | 2012-03-07 | 杭州民生药业有限公司 | 一种三氧化二砷固体脂质纳米粒及其制剂 |
| US8168224B2 (en) * | 2007-12-19 | 2012-05-01 | Beijing Shengyiyao Science & Technology Development Co., Ltd. | Sodium alginate microsphere vascular embolus containing water-soluble drug and preparation and application thereof |
| WO2010032434A1 (ja) | 2008-09-19 | 2010-03-25 | 株式会社アクティバスファーマ | 医療用複合有機化合物粉体、その製造方法ならびに懸濁液 |
| EP2359812A1 (en) | 2010-01-18 | 2011-08-24 | Cephalon France | Oral lyophilised compositions |
| EP2525783A1 (en) | 2010-01-18 | 2012-11-28 | Cephalon France | Improved oral lysophilisates containing pvp/va |
| CN103142648B (zh) * | 2011-12-07 | 2015-04-15 | 浙江中医药大学 | 一种砷化合物溶液及其制备的包载砷化合物的白蛋白纳米粒和冻干制剂 |
| CN103408477B (zh) | 2013-08-22 | 2015-06-10 | 陈鹏飞 | 一种含砷配位化合物及其制备方法 |
| CN107206022B (zh) | 2015-01-29 | 2020-10-16 | 益友制药私人有限公司 | 含砷的组合物及其在治疗方法中的用途 |
| HRP20251032T1 (hr) | 2015-02-01 | 2025-10-24 | Quetzal Therapeutics, Llc | Liofilizirani pripravci s visokim površinskim područjem koji sadrže arsen za oralnu primjenu kod pacijenata |
-
2016
- 2016-02-01 HR HRP20251032TT patent/HRP20251032T1/hr unknown
- 2016-02-01 EP EP25184422.1A patent/EP4599823A1/en active Pending
- 2016-02-01 FI FIEP21192594.6T patent/FI3981414T3/fi active
- 2016-02-01 US US15/012,355 patent/US10111836B2/en active Active
- 2016-02-01 MX MX2017009913A patent/MX390835B/es unknown
- 2016-02-01 WO PCT/US2016/015917 patent/WO2016123603A2/en not_active Ceased
- 2016-02-01 CN CN202311663020.2A patent/CN117899029A/zh active Pending
- 2016-02-01 EP EP21192594.6A patent/EP3981414B1/en active Active
- 2016-02-01 EP EP16744263.1A patent/EP3250214B1/en active Active
- 2016-02-01 JP JP2017559275A patent/JP6928768B2/ja active Active
- 2016-02-01 TW TW111149127A patent/TW202337477A/zh unknown
- 2016-02-01 HU HUE21192594A patent/HUE072537T2/hu unknown
- 2016-02-01 SM SM20250321T patent/SMT202500321T1/it unknown
- 2016-02-01 TW TW110142380A patent/TW202228734A/zh unknown
- 2016-02-01 CA CA2975406A patent/CA2975406C/en active Active
- 2016-02-01 TW TW105103175A patent/TWI790191B/zh active
- 2016-02-01 AU AU2016211186A patent/AU2016211186A1/en not_active Abandoned
- 2016-02-01 LT LTEP21192594.6T patent/LT3981414T/lt unknown
- 2016-02-01 RS RS20250815A patent/RS67133B1/sr unknown
- 2016-02-01 CA CA3225480A patent/CA3225480A1/en active Pending
- 2016-02-01 CN CN201680020478.8A patent/CN107530373B/zh active Active
- 2016-02-01 SI SI201631917T patent/SI3981414T1/sl unknown
- 2016-02-01 ES ES16744263T patent/ES2899226T3/es active Active
- 2016-02-01 ES ES21192594T patent/ES3034734T3/es active Active
- 2016-02-01 PL PL21192594.6T patent/PL3981414T3/pl unknown
- 2016-02-01 PT PT211925946T patent/PT3981414T/pt unknown
- 2016-02-01 DK DK21192594.6T patent/DK3981414T3/da active
-
2017
- 2017-07-31 MX MX2020012611A patent/MX2020012611A/es unknown
-
2018
- 2018-10-01 US US16/148,193 patent/US10272045B2/en active Active
-
2019
- 2019-03-12 US US16/299,214 patent/US10653628B2/en active Active
-
2020
- 2020-04-20 US US16/852,758 patent/US20210069115A1/en not_active Abandoned
-
2021
- 2021-06-07 AU AU2021203752A patent/AU2021203752B2/en active Active
- 2021-06-22 JP JP2021103196A patent/JP7539855B2/ja active Active
-
2023
- 2023-01-27 US US18/160,445 patent/US12364664B2/en active Active
- 2023-08-10 AU AU2023214307A patent/AU2023214307B2/en active Active
-
2024
- 2024-01-10 US US18/408,664 patent/US20240269076A1/en active Pending
- 2024-08-14 JP JP2024135193A patent/JP2024161468A/ja active Pending
-
2025
- 2025-10-29 AU AU2025259861A patent/AU2025259861A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL252915A0 (en) | Immunogenic preparations for use in pneumococcal vaccines | |
| PT3981414T (pt) | Composições liofilizadas de elevada área de superfície compreendendo arsénio para administração oral em doentes | |
| IL256364A (en) | Pharmaceutical formulations containing tenofovir and emtricitabine | |
| IL270812A (en) | Solid compositions for oral drug administration | |
| IL267041A (en) | Medicinal recipes that form a gel on the site | |
| HUP1700253A1 (hu) | Szilárd orális gyógyszerkészítmények | |
| ZA201703562B (en) | Pharmaceutical composition for oral administration comprising taxane | |
| IL240666A0 (en) | Pharmaceutical preparations for oral administration and their uses | |
| HUE061697T2 (hu) | Stabil gyógyszerkészítmény orális adagolásra | |
| GB201801566D0 (en) | Methods and compositions for nanormulsion vaccine formulations | |
| EP3290037A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| PL3326619T3 (pl) | Stałe doustne kompozycje farmaceutyczne zawierające tenofowir i emtrycytabinę | |
| EP3381467A4 (en) | PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION AND METHOD FOR PREPARING A PHARMACEUTICAL VACCINE COMPOSITION FOR ORAL ADMINISTRATION | |
| ZA201604100B (en) | Gastro-retentive oral pharmaceutical compositions | |
| EP2979698A4 (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | |
| PT3377044T (pt) | Composições de ibuprofeno para administração oral direta | |
| PL2953617T3 (pl) | Kompozycje farmaceutyczne zawierające leki w małej dawce | |
| IL264083A (en) | A pharmaceutical preparation containing benzydamine |